Pharmacokinetics and bio-distribution of novel super paramagnetic iron oxide nanoparticles (SPIONs) in the anaesthetized pig

Clinical and Experimental Pharmacology and Physiology

Volumn 43, Issue 3, 2016, Pages 319-326

  Edge, Deirdre ^d   Shortt, Christine M ^a   Gobbo, Oliviero L ^b   Teughels, Stephanie ^c   Prina Mello, Adriele ^b,d   Volkov, Yuri ^b,d   Maceneaney, Peter ^e   Radomski, Marek W ^b   Markos, Farouk ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c PEPRIC NV   (Belgium)

^d TRINITY COLLEGE DUBLIN   (Ireland)

^e MERCY UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Biodistribution; Blood pressure; Electron paramagnetic resonance (pEPR); Magnetic nanoparticles; Magnetic resonance imaging (MRI)

Indexed keywords

SUCCIMER; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; FERRIC ION; FERRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BLOOD PRESSURE; BLOOD SAMPLING; ELECTRON SPIN RESONANCE; HISTOLOGY; LIMIT OF DETECTION; LIVER; LUNG; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHARMACOKINETICS; PIG; PLASMA HALF LIFE; SPLEEN; TISSUE DISTRIBUTION; ANESTHESIA; ANIMAL; BLOOD; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; MAGNET; PARTICLE SIZE;

ANESTHESIA; ANIMALS; BLOOD PRESSURE; FERRIC COMPOUNDS; LUNG; MAGNETIC RESONANCE IMAGING; MAGNETS; PARTICLE SIZE; SWINE; TISSUE DISTRIBUTION;

EID: 84959336049     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12533     Document Type: Article

References (24)

1. Globocan Estimated Cancer Incidence, Mortalitly and Prevelance Worldwide in 2012 World Health Organization. 2012. Available from: http://www.ncri.ie/news/article/iarc-release-globocan-2012-global-cancer-burden-rises-141-million-new-cases-2012-and (accessed 29 December 2015).
2. Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 2004; 56: 1649-59.
3. Colombo M, Carregal-Romero S, Casula MF et al. Biological applications of magnetic nanoparticles. Chem. Soc. Rev. 2012; 41: 4306-34.
4. Hilger I, Kaiser WA. Iron oxide-based nanostructures for MRI and magnetic hyperthermia. Nanomedicine (Lond.) 2012; 7: 1443-59.
5. Iversen NK, Frische S, Thomsen K et al. Superparamagnetic iron oxide polyacrylic acid coated gamma-Fe2O3 nanoparticles do not affect kidney function but cause acute effect on the cardiovascular function in healthy mice. Toxicol. Appl. Pharmacol. 2013; 266: 276-88.
6. Chouly C, Pouliquen D, Lucet I, Jeune JJ, Jallet P. Development of superparamagnetic nanoparticles for MRI: Effect of particle size, charge and surface nature on biodistribution. J. Microencapsul. 1996; 13: 245-55.
7. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005; 26: 3995-4021.
8. Prina-Mello A, Crosbie-Staunton K, Salas G, del Puerto Morales M, Volkov Y. Multiparametric toxicity evaluation of SPIONs by high content screening technique: Identification of biocompatible multifunctional nanoparticles for nanomedicine magnetics. IEEE Trans. 2013; 49: 377-82.
9. Gobbo OL, Wetterling F, Vaes P et al. Biodistribution and pharmacokinetic studies of SPION using particle electron paramagnetic resonance, MRI and ICP-MS. Nanomedicine (Lond.) 2015; 10: 1751-60.
10. Salas G, Casado C, Teran FJ, Miranda R, Serna CJ, Morales MP. Controlled synthesis of uniform magnetite nanocrystals with high-quality properties for biomedical applications. J. Mater. Chem. 2012; 22: 21065-75.
11. Vlasova MA, Tarasova OS, Riikonen J et al. Injected nanoparticles: The combination of experimental systems to assess cardiovascular adverse effects. Eur. J. Pharm. Biopharm. 2014; 87: 64-72.
12. Bu L, Xie J, Chen K et al. Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma. Contrast Media Mol. Imaging 2012; 7: 363-72.
13. Ruiz A, Hernandez Y, Cabal C et al. Biodistribution and pharmacokinetics of uniform magnetite nanoparticles chemically modified with polyethylene glycol. Nanoscale 2013; 5: 11400-8.
14. Corot C, Robert P, Idee JM, Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv. Drug Deliv. Rev. 2006; 58: 1471-504.
15. Gutiérrez L, Morales MP, Lázaro FJ. Prospects for magnetic nanoparticles in systemic administration: Synthesis and quantitative detection. Phys. Chem. Chem. Phys. 2014; 16: 4456-64.
16. Subcommittee on Swine Nutrition CoAN. National Research Council Nutrient Requirements of Swine: 10th Revised Edition. The National Academies Press, Washington, DC, 1998.
17. Danhier P, De Preter G, Boutry S et al. Electron paramagnetic resonance as a sensitive tool to assess the iron oxide content in cells for MRI cell labeling studies. Contrast Media Mol. Imaging 2012; 7: 302-7.
18. Jain TK, Reddy MK, Morales MA, Leslie-Pelecky DL, Labhasetwar V. Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. Mol. Pharm. 2008; 5: 316-27.
19. Mejias R, Pérez-Yagüe S, Gutiérrez L et al. Dimercaptosuccinic acid-coated magnetite nanoparticles for magnetically guided in vivo delivery of interferon gamma for cancer immunotherapy. Biomaterials 2011; 32: 2938-52.
20. Hanini A, Schmitt A, Kacem K, Chau F, Ammar S, Gavard J. Evaluation of iron oxide nanoparticle biocompatibility. Int. J. Nanomedicine 2011; 6: 787-94.
21. Mejias R, Pérez-Yagüe S, Roca AG et al. Liver and brain imaging through dimercaptosuccinic acid-coated iron oxide nanoparticles. Nanomedicine (Lond.) 2010; 5: 397-408.
22. Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 2002; 54: 631-51.
23. Kommareddy S, Amiji M. Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice. J. Pharm. Sci. 2007; 96: 397-407.
24. Chaves SB, Silva LP, Lacava ZGM, Morais PC, Azevedo RB. Interleukin-1 and interleukin-6 production in mice's lungs induced by 2, 3 meso-dimercaptosuccinic-coated magnetic nanoparticles. J. Appl. Phys. 2005; 97: 10Q915-10Q915-3.